anmelden
NYSE US 100
18.163,06
PKT
-133,28
PKT
-0,73
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE US 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.02.26 | Walmart Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Bayer Overweight | Barclays Capital | |
| 18.02.26 | Bayer Verkaufen | DZ BANK | |
| 18.02.26 | Bayer Neutral | UBS AG | |
| 18.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 18.02.26 | Coca-Cola Overweight | Barclays Capital | |
| 18.02.26 | Bayer Overweight | Barclays Capital | |
| 18.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 18.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 17.02.26 | Coca-Cola Overweight | JP Morgan Chase & Co. | |
| 17.02.26 | Bayer Hold | Jefferies & Company Inc. | |
| 17.02.26 | JPMorgan Chase Overweight | Barclays Capital | |
| 17.02.26 | Boeing Outperform | Bernstein Research | |
| 16.02.26 | Bayer Neutral | UBS AG | |
| 16.02.26 | McDonalds Kaufen | DZ BANK | |
| 13.02.26 | FedEx Buy | Jefferies & Company Inc. | |
| 13.02.26 | JPMorgan Chase Overweight | Barclays Capital | |
| 13.02.26 | FedEx Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | McDonalds Overweight | JP Morgan Chase & Co. | |
| 12.02.26 | McDonalds Overweight | Barclays Capital | |
| 12.02.26 | McDonalds Sector Perform | RBC Capital Markets | |
| 11.02.26 | Coca-Cola Kaufen | DZ BANK | |
| 11.02.26 | Coca-Cola Buy | UBS AG | |
| 11.02.26 | Coca-Cola Overweight | JP Morgan Chase & Co. | |
| 11.02.26 | Coca-Cola Outperform | RBC Capital Markets | |
| 10.02.26 | Boeing Outperform | RBC Capital Markets | |
| 10.02.26 | Coca-Cola Overweight | Barclays Capital | |
| 10.02.26 | Coca-Cola Overweight | JP Morgan Chase & Co. | |
| 10.02.26 | Coca-Cola Buy | Jefferies & Company Inc. | |
| 10.02.26 | Coca-Cola Outperform | RBC Capital Markets | |
| 10.02.26 | FedEx Overweight | Barclays Capital | |
| 09.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 06.02.26 | Bayer Overweight | Barclays Capital | |
| 06.02.26 | Bayer Neutral | UBS AG | |
| 06.02.26 | Bayer Buy | Goldman Sachs Group Inc. | |
| 05.02.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Bayer Overweight | Barclays Capital | |
| 04.02.26 | FedEx Buy | UBS AG | |
| 04.02.26 | Eli Lilly Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Pfizer Neutral | Goldman Sachs Group Inc. |